Centessa Historical Financial Ratios
| CNTA Stock | USD 14.59 0.08 0.55% |
Centessa Pharmaceuticals is presently reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 5.01 or Days Sales Outstanding of 1.7 K will help investors to properly organize and evaluate Centessa Pharmaceuticals financial condition quickly.
Centessa |
About Centessa Financial Ratios Analysis
Centessa PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Centessa Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Centessa financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Centessa Pharmaceuticals history.
Centessa Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Centessa Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Centessa Pharmaceuticals sales, a figure that is much harder to manipulate than other Centessa Pharmaceuticals PLC multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Centessa Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Centessa Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At present, Centessa Pharmaceuticals' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 5.01, whereas Book Value Per Share is forecasted to decline to 2.38.
| 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 10.27 | 8.0 | 9.25 | 11.65 | Net Debt To EBITDA | 1.53 | 0.26 | 1.86 | 1.96 |
Centessa Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Centessa Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Centessa Pharmaceuticals fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Free Cash Flow Yield | (0.00344) | (0.13) | (0.7) | (0.21) | (0.0741) | (0.0778) | |
| Operating Cash Flow Per Share | (0.0748) | (1.51) | (2.15) | (1.67) | (1.24) | (1.3) | |
| Free Cash Flow Per Share | (0.0748) | (1.51) | (2.16) | (1.67) | (1.24) | (1.3) | |
| Net Income Per Share | (0.0777) | (4.24) | (2.31) | (1.57) | (2.06) | (2.16) | |
| Pocfratio | (290.66) | (7.44) | (1.44) | (4.77) | (13.5) | (14.17) | |
| Interest Coverage | (27.62) | (54.66) | (30.18) | (17.29) | 19.93 | 20.92 | |
| Pfcf Ratio | (290.66) | (7.43) | (1.44) | (4.77) | (13.49) | (14.17) | |
| Income Quality | 1.0 | 0.36 | 0.93 | 1.06 | 0.6 | 0.94 | |
| Pe Ratio | (279.84) | (2.65) | (1.34) | (5.07) | (8.13) | (8.54) | |
| Earnings Yield | (0.003573) | (0.38) | (0.75) | (0.2) | (0.12) | (0.13) | |
| Price Earnings Ratio | (279.84) | (2.65) | (1.34) | (5.07) | (8.13) | (8.54) | |
| Price To Operating Cash Flows Ratio | (290.66) | (7.44) | (1.44) | (4.77) | (13.5) | (14.17) | |
| Price To Free Cash Flows Ratio | (290.66) | (7.43) | (1.44) | (4.77) | (13.49) | (14.17) | |
| Effective Tax Rate | (0.0354) | (2.99E-4) | 0.003443 | 0.14 | (0.0122) | (0.0116) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centessa Pharmaceuticals. If investors know Centessa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centessa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centessa Pharmaceuticals is measured differently than its book value, which is the value of Centessa that is recorded on the company's balance sheet. Investors also form their own opinion of Centessa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Centessa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centessa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Centessa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centessa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Centessa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centessa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.